SAKAR HEALTHCARE
Back to Income Statement
|
SAKAR HEALTHCARE Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹133 Cr | ₹128 Cr | ₹95 Cr | ₹8,298,024 Cr | ₹83 Cr |
What is the latest Revenue of SAKAR HEALTHCARE ?
Year | Revenue |
---|---|
Mar2024 | ₹133 Cr |
Mar2023 | ₹128 Cr |
Mar2022 | ₹95 Cr |
Mar2021 | ₹8,298,024 Cr |
Mar2020 | ₹83 Cr |
How is Revenue of SAKAR HEALTHCARE Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹133 Cr | 4.00 | |
Mar2023 | ₹128 Cr | 35.35 | |
Mar2022 | ₹95 Cr | -100.00 | |
Mar2021 | ₹8,298,024 Cr | 9,999,928.87 | |
Mar2020 | ₹83 Cr | - |
Compare Revenue of peers of SAKAR HEALTHCARE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SAKAR HEALTHCARE | ₹780.7 Cr | -3.2% | 7.6% | 11.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,017.0 Cr | -0.2% | -0.5% | 10.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,867.0 Cr | 4% | 4.8% | 50.5% | Stock Analytics | |
CIPLA | ₹122,451.0 Cr | 0.4% | 3.1% | 1.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹115,620.0 Cr | 5.9% | 9.1% | 23% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,572.0 Cr | -4.8% | 2.2% | 2.9% | Stock Analytics |
SAKAR HEALTHCARE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SAKAR HEALTHCARE | -3.2% |
7.6% |
11.9% |
SENSEX | 2% |
2.8% |
6.4% |
You may also like the below Video Courses